Cargando…

Hematopoietic cytokines as therapeutic players in early stages Parkinson’s disease

Parkinson’s disease (PD) is a devastating age related neurodegenerative disease that is believed to have a lengthy prodromal state. It is critical to find methods to harness compensatory recovery processes in order to slow or prevent the eventual progression of clinical symptoms. The current perspec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Farmer, Kyle, Rudyk, Christopher, Prowse, Natalie A., Hayley, Shawn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2015
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4490238/ https://www.ncbi.nlm.nih.gov/pubmed/26191001 http://dx.doi.org/10.3389/fnagi.2015.00126

Ejemplares similares

Age and Chronicity of Administration Dramatically Influenced the Impact of Low Dose Paraquat Exposure on Behavior and Hypothalamic-Pituitary-Adrenal Activity
por: Rudyk, Chris A., et al.
Publicado: (2017)

Chronic unpredictable stress influenced the behavioral but not the neurodegenerative impact of paraquat
por: Rudyk, Chris, et al.
Publicado: (2019)

Major Alterations of Phosphatidylcholine and Lysophosphotidylcholine Lipids in the Substantia Nigra Using an Early Stage Model of Parkinson’s Disease
por: Farmer, Kyle, et al.
Publicado: (2015)

Cytokine activity in Parkinson’s disease
por: Dzamko, Nicolas
Publicado: (2023)

Brain-derived neurotrophic factor (BDNF) has direct anti-inflammatory effects on microglia
por: Charlton, Tryston, et al.
Publicado: (2023)

Perinatal antibiotic exposure alters composition of murine gut microbiota and may influence later responses to peanut antigen
por: Boutin, Rozlyn C. T., et al.
Publicado: (2018)

Methods for Surgical Targeting of the STN in Early-Stage Parkinson’s Disease
por: Camalier, Corrie R., et al.
Publicado: (2014)

Stability of motor-nonmotor subtype in early-stage Parkinson’s disease
por: Xiao, Yi, et al.
Publicado: (2022)

Use of induced pluripotent stem cell derived neurons engineered to express BDNF for modulation of stressor related pathology
por: Liu, Gele, et al.
Publicado: (2014)

Cytokines in atherosclerosis: Key players in all stages of disease and promising therapeutic targets
por: Ramji, Dipak P., et al.
Publicado: (2015)

Rab GTPases: The Key Players in the Molecular Pathway of Parkinson’s Disease
por: Shi, Meng-meng, et al.
Publicado: (2017)

Nicotinic Acetylcholine Receptor Density in Cognitively Intact Subjects at an Early Stage of Parkinson’s Disease
por: Isaias, Ioannis Ugo, et al.
Publicado: (2014)

LRRK2 and α-Synuclein: Distinct or Synergistic Players in Parkinson’s Disease?
por: O’Hara, Darren M., et al.
Publicado: (2020)

Differentiation of Parkinson’s disease and Parkinsonism predominant multiple system atrophy in early stage by morphometrics in susceptibility weighted imaging
por: Ren, Qingguo, et al.
Publicado: (2022)

Striatum Shape Hypertrophy in Early Stage Parkinson’s Disease With Excessive Daytime Sleepiness
por: Gong, Liang, et al.
Publicado: (2020)

Enteric glia as a player of gut-brain interactions during Parkinson’s disease
por: Thomasi, Beatriz, et al.
Publicado: (2023)

Changes in Cortical Thickness in Patients With Early Parkinson’s Disease at Different Hoehn and Yahr Stages
por: Gao, Yuyuan, et al.
Publicado: (2018)

Increased Plasma Heme Oxygenase-1 Levels in Patients With Early-Stage Parkinson’s Disease
por: Sun, Wenhua, et al.
Publicado: (2021)

The Pathological Mechanism Between the Intestine and Brain in the Early Stage of Parkinson's Disease
por: Yang, Runing, et al.
Publicado: (2022)

Interaction of Alpha-Synuclein With Lipids: Mitochondrial Cardiolipin as a Critical Player in the Pathogenesis of Parkinson’s Disease
por: Gilmozzi, Valentina, et al.
Publicado: (2020)

People in early stages of Parkinson’s disease are able to intentionally reweight the use of visual information for postural control
por: Cruz, Caio F., et al.
Publicado: (2020)

Topological Abnormalities of Functional Brain Network in Early-Stage Parkinson’s Disease Patients With Mild Cognitive Impairment
por: Chen, Xiangbin, et al.
Publicado: (2020)

Aberrant Changes in Cortical Complexity in Right-Onset Versus Left-Onset Parkinson’s Disease in Early-Stage
por: Zhang, Lin, et al.
Publicado: (2021)

Cognitive Deficit and Aberrant Intrinsic Brain Functional Network in Early-Stage Drug-Naive Parkinson’s Disease
por: Zhang, Lan, et al.
Publicado: (2022)

Mitophagy in Parkinson’s Disease: Pathogenic and Therapeutic Implications
por: Gao, Fei, et al.
Publicado: (2017)

Editorial: Cytokines as Players of Neuronal Plasticity and Sensitivity to Environment in Healthy and Pathological Brain
por: Alboni, Silvia, et al.
Publicado: (2016)

Neuroinflammation in early, late and recovery stages in a progressive parkinsonism model in rats
por: Cunha, Debora M. G., et al.
Publicado: (2022)

Impact of Parkinson’s Disease on Functional Mobility at Different Stages
por: Mollà-Casanova, Sara, et al.
Publicado: (2022)

Centrality of Early Synaptopathy in Parkinson’s Disease
por: Imbriani, Paola, et al.
Publicado: (2018)

Leucine-rich repeat kinase-2 (LRRK2) modulates paraquat-induced inflammatory sickness and stress phenotype
por: Rudyk, Chris, et al.
Publicado: (2019)

C-Gait for Detecting Freezing of Gait in the Early to Middle Stages of Parkinson’s Disease: A Model Prediction Study
por: Chen, Zi-Yan, et al.
Publicado: (2021)

Motor Progression in Early-Stage Parkinson's Disease: A Clinical Prediction Model and the Role of Cerebrospinal Fluid Biomarkers
por: Ma, Ling-Yan, et al.
Publicado: (2021)

Adaptation strategies and neurophysiological response in early-stage Parkinson's disease: BioVRSea approach
por: Jacob, Deborah, et al.
Publicado: (2023)

Future Therapeutic Strategies for Freezing of Gait in Parkinson’s Disease
por: Cui, Cathy K., et al.
Publicado: (2021)

Alterations of Regional Homogeneity in the Mild and Moderate Stages of Parkinson’s Disease
por: Li, Junli, et al.
Publicado: (2021)

Cerebellar functional connectivity change is associated with motor and neuropsychological function in early stage drug-naïve patients with Parkinson’s disease
por: Jiang, Li, et al.
Publicado: (2023)

Effects of a probiotic suspension Symprove™ on a rat early-stage Parkinson’s disease model
por: Sancandi, Marco, et al.
Publicado: (2023)

Alterations of NURR1 and Cytokines in the Peripheral Blood Mononuclear Cells: Combined Biomarkers for Parkinson’s Disease
por: Li, Tianbai, et al.
Publicado: (2018)

The class II histone deacetylases as therapeutic targets for Parkinson’s disease
por: Mazzocchi, Martina, et al.
Publicado: (2020)

Associations between Early Markers of Parkinson's Disease and Sarcopenia
por: Drey, Michael, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_5so6cdaltro5fj747m51rielk6